Physicians Formula Holdings, Inc. Merger Litigation (Nasdaq: FACE)
Law Office of Brodsky & Smith, LLC Announces Investigation of Physicians Formula Holdings, Inc.
BALA CYNWYD, August 16, 2012/PR Newswire/ –Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Physicians Formula Holdings, Inc. (“Physicians Formula” or the “Company”) (Nasdaq- FACE-News) relating to the proposed acquisition by Swander Pace Capital, Inc. (“Swander”).
Under the terms of the transaction, Physicians Formula shareholders would receive only $4.25 in cash for each share of Physicians Formula stock they own. The investigation concerns possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Physicians Formula for not acting in the Company’s shareholders' best interests in connection with the sale process to Swander. The transaction may undervalue Company as Physicians Formula stock traded at $5.74 on May 12, 2011 and an analyst has set a $5.00 price target for Physicians Formula stock.
If you own shares of Physicians Formula stock and wish to discuss the legal ramifications of the proposed transaction, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail at firstname.lastname@example.org, or by calling toll free 877-LEGAL-90.
To Join the Physicians Formula Holdings, Inc. Litigation
Fill out this form
The complaint is unavailable at this time